Amneal Pharmaceuticals, Inc. AMRX Total debt

Total debt at other companies

PfizerPFE

$64.43B+4.9%

McKessonMCK

$12.97B+15.7%

ANI PharmaceuticalsANIP

$301.48M-4.2%

CencoraCOR

$11.72B+45.7%

Jazz PharmaceuticalsJAZZ

$5.4B-0.1%

Cardinal HealthCAH

——

FAQ

What is Amneal Pharmaceuticals, Inc.'s total debt?

Amneal Pharmaceuticals, Inc. (AMRX) reported total debt of $2.57B in Q2 2026.

How has Amneal Pharmaceuticals, Inc.'s total debt changed year-over-year?

Amneal Pharmaceuticals, Inc.'s total debt increased by 18.0% year-over-year, from $2.18B to $2.57B.

What is the long-term trend for Amneal Pharmaceuticals, Inc.'s total debt?

Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s total debt has grown at a -1.5% compound annual growth rate (CAGR), from $2.91B to $2.69B.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.